Funding Search - Pivot

The University of Vermont, through Sponsored Project Administration (SPA) subscribes to Pivot, a web-based funding search tool. The UVM Cancer Center has collaborated with SPA to create a customized cancer relevant pivot search. Press the button for Cancer Funding Opportunities.

Cancer Funding Opportunities


If you would prefer to set up your own pivot search and automated alerts you can learn more about pivot HERE.

Limited Competition Funding

Limited Competitions (where the University may only submit a restricted number of applications) are managed though UVM's InfoReady Portal for Institutional Competitions. Go to to see all available competitions and enter “cancer” into the search box to see only cancer-specific opportunities.

You can also contact Edward North for information on applying for Limited Funding Opportunities. 

Peer-Reviewed Funding Sources

Below is a list of fund sources from federal agencies, non-profit foundations and regional and national organizations to support cancer research are provided below for UVM Cancer Center researchers. This of funding is considered NCI approved peer-reviewed funding and can also be found in PDF format at the following link: NCI Peer-Reviewed Fund Sources

  1. Agency for Healthcare Research and Quality (AHRQ)
  2. Alex’s Lemonade Stand Foundation (ALSF)
  3. American Association of Cancer Research (AACR)
  4. American Cancer Society (ACS) (national office only)
  5. American Foundation for AIDS Research (amfAR)
  6. American Institute for Cancer Research (AICR)
  7. California Institute for Regenerative Medicine (CIRM)
  8. Cancer Prevention Research Institute of Texas (CPRIT)
  9. Center for Disease Control and Prevention (CDC)
  10. Central Office of the Veterans Administration (VA) (excluding local/regional & “block” grants)
  11. Environmental Protection Agency (EPA)
  12. The Flight Attendant Medical Research Institute (FAMRI)
  13. Florida Biomedical Research Program (FBRP)
  14. Food and Drug Administration (FDA)
  15. Howard Hughes Medical Institute (HHMI)
  16. Leukemia and Lymphoma Society (LLS)
  17. Melanoma Research Alliance (MRA)
  18. Multiple Myeloma Research Foundation (MMRF)
  19. National Institute for Occupational Safety and Health (NIOSH)
  20. National Science Foundation (NSF)
  21. New York State Department of Health Wadsworth Center/New York State Stem Cell Science Program (NYSTEM)
  22. Patient-Centered Outcomes Research Institute (PCORI)
  23. Prevent Cancer Foundation (PCF)
  24. Prostate Cancer Foundation (PCF)
  25. Susan G. Komen for the Cure
  26. The California Breast Cancer Research Program (CBCRP)
  27. The California Tobacco Related Disease Research Program (TRDRP)
  28. U.S. Army (DOD) special research programs *


For Pivot Assistance

For information on scheduling a Pivot-RP tutorial or to request a funding search, please visit here

Should you learn of an opportunity not listed here but important to UVM Cancer Center research, please contact Edward North.

UVMCC Facilities & Resources Descriptions

“Boilerplate” descriptions of UVM Cancer Center-affiliated Resources & Facilities are provided at the links below. These are primarily intended for use in grant applications, including the “Facilities & Resources” section of NIH funding applications. Users are strongly urged to personalize the description to the greatest extent possible by adding details such as a history of collaboration resulting in publications and/or funded research awards.
University of Vermont Cancer Center (UVMCC)
Cancer Translational Research Laboratory (CTRL)
Clinical Trials Office (CTO)
Microscopy Imaging Center (MIC)
Vermont Integrative Genomics Resource (VIGR)


Highlights: New & Updated

New and Updated

Department of Defense
Congressionally Directed Medical Research Programs (CDMRP)
Breast Cancer Research Program (BCRP)
Anticipated Funding Opportunities for Fiscal Year 2022 (FY22)

Applications submitted to the FY22 BCRP must address one or more of the following overarching challenges:

  • Prevent breast cancer (primary prevention)
  • Identify determinants of breast cancer initiation, risk, or susceptibility
  • Distinguish deadly from non-deadly breast cancers
  • Conquer the problems of overdiagnosis and overtreatment
  • Identify what drives breast cancer growth; determine how to stop it
  • Identify why some breast cancers become metastatic
  • Determine why/how breast cancer cells lie dormant for years and then re-emerge; determine how to prevent lethal recurrence
  • Revolutionize treatment regimens by replacing them with ones that are more effective, less toxic, and impact survival
  • Eliminate the mortality associated with metastatic breast cancer
Learn more here: